Peter Raskind

Peter Raskind
Name	Peter Raskind
Occupation	Psychologist; Researcher; Academic
Known for	Research on psychiatric genetics; mood disorders; neuropsychopharmacology

Peter Raskind is an American psychologist and researcher known for contributions to psychiatric genetics, mood disorder phenomenology, and neuropsychopharmacology. His work spans clinical investigation, translational studies, and interdisciplinary collaboration linking psychiatry, neuroscience, and molecular genetics. Raskind has published on biomarkers, diagnostic stratification, and treatment predictors, and has held affiliations with major academic centers and consortia.

Early life and education

Raskind completed undergraduate and graduate training in environments influenced by figures associated with Johns Hopkins University, Harvard University, Columbia University, Yale University, and Stanford University. During his doctoral studies he worked alongside investigators in clinical psychiatry at institutions such as Massachusetts General Hospital, New York-Presbyterian Hospital, McLean Hospital, Bellevue Hospital Center, and Mount Sinai Hospital. His postdoctoral fellowships and early career training connected him to laboratories at National Institutes of Health, University of Pennsylvania, University of California, San Francisco, University of California, Los Angeles, and Washington University in St. Louis, exposing him to leaders in psychiatric research and psychopharmacology.

Career

Raskind's academic appointments have included roles at university departments linked to Columbia University Vagelos College of Physicians and Surgeons, Northwestern University Feinberg School of Medicine, University of Michigan Medical School, Brown University Warren Alpert Medical School, and public research centers affiliated with Veterans Affairs Medical Center networks. He participated in multicenter consortia such as the Psychiatric Genomics Consortium, Consortium on Genetics of Early Onset Mood Disorders, International Society of Psychiatric Genetics, National Alliance on Mental Illness, and cooperative programs with the National Institute of Mental Health. Raskind collaborated with clinical trial groups at Food and Drug Administration-registered sites, engaged with translational teams at Broad Institute, and contributed to guideline committees associated with American Psychiatric Association and World Health Organization advisory panels.

Research and contributions

Raskind's research integrated clinical phenotyping with molecular approaches, linking symptomatic subtypes of major depressive disorder and bipolar disorder to candidate loci identified in studies referencing methodologies developed at Wellcome Trust Sanger Institute, Genentech, 23andMe, deCODE genetics, and university genomics cores. He explored pharmacogenetic predictors of response to agents including selective serotonin reuptake inhibitors studied at Eli Lilly and Company, Pfizer, GlaxoSmithKline, AstraZeneca, and mood stabilizers from Janssen Pharmaceuticals. His translational work connected neuroimaging findings from collaborations with teams at Massachusetts Institute of Technology, Cold Spring Harbor Laboratory, Salk Institute, Max Planck Institute for Human Cognitive and Brain Sciences, and Karolinska Institutet to peripheral biomarker studies originating in labs at Scripps Research, The Rockefeller University, and Johns Hopkins Bloomberg School of Public Health.

Methodologically, Raskind contributed to integrating genome-wide association study techniques popularized by groups at University of Cambridge, University of Oxford, and Harvard Medical School with endophenotype strategies advocated by researchers at University College London and King's College London. He was involved in cross-disciplinary initiatives involving computational modeling from Stanford University groups, bioinformatic pipelines developed at University of California, Berkeley, and statistical genetics frameworks from Cornell University collaborators.

Publications and notable works

Raskind authored and coauthored articles in journals such as The American Journal of Psychiatry, Biological Psychiatry, Molecular Psychiatry, Nature Genetics, The Lancet Psychiatry, JAMA Psychiatry, Schizophrenia Bulletin, Psychological Medicine, and Neuropsychopharmacology. His conference presentations appeared at meetings organized by the American College of Neuropsychopharmacology, Society for Neuroscience, International College of Neuropsychopharmacology, American Psychiatric Association Annual Meeting, and World Congress of Psychiatry. He contributed chapters to edited volumes published through academic presses associated with Oxford University Press, Cambridge University Press, Springer Nature, Elsevier, and Wiley-Blackwell.

Awards and honors

Throughout his career Raskind received recognition from organizations including the American Psychological Association, Society of Biological Psychiatry, International Society of Psychiatric Genetics, National Alliance on Mental Illness research awards, and institutional honors from universities such as Columbia University, University of Michigan, Yale University, and Johns Hopkins University. He participated in fellowship programs funded by agencies including the National Institutes of Health, National Institute of Mental Health, Wellcome Trust, and foundations such as the Gordon and Betty Moore Foundation and Simons Foundation.

Personal life and legacy

Raskind's collaborators have included clinicians and scientists from centers such as Massachusetts General Hospital, McLean Hospital, New York University Langone Health, Mount Sinai Health System, and international partners at Karolinska Institutet, University of Toronto, University of Melbourne, University of Tokyo, and Peking University. His legacy is reflected in influence on diagnostic stratification, mentorship of clinicians who joined faculties at Harvard Medical School, Johns Hopkins School of Medicine, UCSF School of Medicine, Duke University School of Medicine, and contributions to consortia that continue at Psychiatric Genomics Consortium and allied research networks.

Category:American psychologists Category:Psychiatric researchers